Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Device Embolization After Percutaneous Left Atrial Appendage Occlusion: Risk Factors, Approaches and Outcomes

NCT05014477 is registered in ClinicalTrials.gov with Cardiovascular Center Frankfurt as lead sponsor.

NCT NCT05014477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05014477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Device Embolization After Percutaneous Left Atrial Appendage Occlusion: Risk Factors, Approaches and Outcomes
Lead sponsor
Cardiovascular Center Frankfurt
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2020
Completion date
December 31, 2023
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

device embolisation, left atrial appendage occluder, risk factors, therapy strategies